Chapter 4 References
Bahji, A., Vazquez, G. H., & Zarate Jr, C. A. (2021). Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis. Journal of affective disorders, 278, 542–555.
Caroff, S. N., & Campbell, E. C. (2016). Drug-induced extrapyramidal syndromes: Implications for contemporary practice. Psychiatric Clinics, 39(3), 391–411.
Fitzgerald, P. B. (2021). Targeting repetitive transcranial magnetic stimulation in depression: Do we really know what we are stimulating and how best to do it? Brain Stimulation, 14(3), 730–736.
Hodo, D. W. (2006). Kaplan and Sadock’s comprehensive textbook of psychiatry. American Journal of Psychiatry, 163(8), 1458.
Ioannou, A., Papastavrou, E., Avraamides, M. N., & Charalambous, A. (2020). Virtual reality and symptoms management of anxiety, depression, fatigue, and pain: A systematic review. SAGE open nursing, 6, 2377960820936163.
Krzystanek M, Surma S, Stokrocka M, Romańczyk M, Przybyło J, Krzystanek N, Borkowski M. (2021). Tips for Effective Implementation of Virtual Reality Exposure Therapy in Phobias-A Systematic Review. Front Psychiatry. Sep 21;12:737351. doi: 10.3389/fpsyt.2021.737351. PMID: 34621197; PMCID: PMC8490820.
McCance, K. L., & Huether, S. E. (2018). Pathophysiology: The biologic basis for disease in adults and children. Philadelphia: Elsevier Health Sciences.
Purves, D., Augustine, G. J., Fitzpatrick, D., Hall, W., LaMantia, A. S., & White, L. (2019). Neurosciences. Vlaams-Brabant, Belgium: De Boeck Supérieur.
Stahl, S. M. (2021). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications. Cambridge, England: Cambridge University Press.
Wheeler, K. (2013). Psychotherapy for the advanced practice psychiatric nurse: A how-to guide for evidence-based practice. New York: Springer Publishing Company.
